Gross, Neil

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

Amaria, R. N., Reddy, S. M., Tawbi, H. A., Davies, M. A., Ross, M. I., Glitza, I. C., Cormier, J. N., Lewis, C., Hwu, W.-J., Hanna, E., et al. (2018) · Nature Medicine

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 835

Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAF V600E -Mutated Anaplastic Thyroid Carcinoma

Wang, J. R., Zafereo, M. E., Dadu, R., Ferrarotto, R., Busaidy, N. L., Lu, C., Ahmed, S., Gule-Monroe, M. K., Williams, M. D., Sturgis, E. M., et al. (2019) · Thyroid®

Thyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid Surgery

Cited by 230

Risk prediction models for head and neck cancer in the US population from the INHANCE consortium

Lee, Y.-C. A., Al-Temimi, M., Ying, J., Muscat, J., Olshan, A. F., Zevallos, J. P., Winn, D. M., Li, G., Sturgis, E. M., Morgenstern, H., et al. (2020) · American Journal of Epidemiology

Head and Neck Cancer StudiesOral Health Pathology and Treatment

Cited by 32